Saul Fink

Saul is a biotech and pharmaceutical R&D leader. He has led CMC teams across many therapeutic areas for both small molecule and biologic assets. He is currently Vice President, Pharmaceutical Development at Goldfinch Bio where he leads teams for small molecule and biological assets to provide CMC strategic guidance, budgets and all operational activities to establish a supply chain for clinical supplies. He also leads all strategic and operational aspects for nonclinical development. He is a member of the Senior Leadership Team.